{
 "as_of": "2026-11-06",
 "cmr": "kr-cm-kg/KOSDAQ/293780",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Aptabio Therapeutics Inc. (KOSDAQ: 293780) — research page\n\nAs of 2026-11-06 · kr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Aptabio Therapeutics Inc., listed on KOSDAQ under ticker 293780, with ISIN KR7293780003. The LEI is not on the record; no GLEIF record is registered as 135-86-03821. The security type is Corporate, the segment is not on the record, the sector is 자연과학 및 공학 연구개발업, and the jurisdiction is South Korea as a DART filer with a corporate registration number. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 29 filings across 24 filing days in the window 2025-11-06 to 2026-11-06. The filings are 4 agm_egm, 19 corporate_news, 1 regulatory_filing and 5 results. The median gap between filing days is 8 days. The record date is 2026-11-06, and the latest filing is dated 2026-10-14, a corporate_news filing, 23 days before the record date. The KOSDAQ median is 33 filings, a median cadence gap of 8.0 days and a median latency of 16.0 days across 1819 issuers. The sector median is 42.5 filings, a median cadence gap of 7 days and a median latency of 15 days across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 정진세림회계법인. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nThe listing, delisting, name change, domicile change and segment move lines are not on the record, because no lifecycle type map exists for this register yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read; the count is 0.\n\n## Open research\n\nThe record holds 5 openly published research notes: IV Research on 2025-12-22, 상상인증권리서치센터 on 2025-02-24, IV Research on 2025-01-08, 상상인증권리서치센터 on 2021-12-20, and Bookook Research Center on 2020-10-12.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.\n\n## Sources\n\n13 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange)\n- https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin)\n- https://opendart.fss.or.kr/api/company.json?corp_code=01251595 (identity.jurisdiction)\n- https://mcp.kr-cm-kg.ai/events/KOSDAQ/293780 (the disclosure lines)\n- https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag)\n- https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323001542 (the auditor)\n- https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://aptabio.com/upload/board/information/20251222_073933_138.pdf (open research)\n- https://aptabio.com/upload/board/information/20250224_100737_363.pdf (open research)\n- https://aptabio.com/upload/board/information/20250224_105656_425.pdf (open research)\n- https://aptabio.com/upload/board/information/20250224_102110_567.pdf (open research)\n- https://aptabio.com/upload/board/information/20250224_101525_627.pdf (open research)\n- https://mcp.kr-cm-kg.ai/record/KOSDAQ/293780 (the record)\n",
 "market": "KR",
 "node": "kr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-12",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the KR store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "DART API 회계감사인의 명칭 및 감사의견 (annual report 11011, business year 2025)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323001542",
    "state": "sourced",
    "value": "정진세림회계법인"
   },
   "auditor_firm_id": {
    "market": "KR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "KR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "kr-cm-kg/KOSDAQ/293780",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1819,
     "median_cadence_gap_days": 8,
     "median_filings": 33,
     "median_latency_days": 16,
     "name": "KOSDAQ"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 7,
     "median_filings": 42.5,
     "median_latency_days": 15,
     "name": "자연과학 및 공학 연구개발업"
    }
   },
   "by_type": {
    "agm_egm": 4,
    "corporate_news": 19,
    "regulatory_filing": 1,
    "results": 5
   },
   "cadence_median_gap_days": 8,
   "filing_days": 24,
   "filings": 29,
   "latency_days": 23,
   "latest": [
    {
     "category": null,
     "date": "2026-10-14",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261014900633",
     "title": "투자판단관련주요경영사항(임상시험결과)              (조영제유발급성신장손상(CIAKI) 치료제 Isuzinaxib(APX115)의 임상시험 제2상 Topline data수령)",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-09-02",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260902900270",
     "title": "기업설명회(IR)개최",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-08-24",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260824900106",
     "title": "전환사채(해외전환사채포함)발행후만기전사채취득",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-08-14",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814002182",
     "title": "반기보고서 (2026.06)",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-07-24",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260724900529",
     "title": "전환가액의조정",
     "type": "corporate_news"
    }
   ],
   "latest_filing_date": "2026-10-14",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSDAQ/293780",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "KOSDAQ"
   },
   "isin": {
    "read_by": "KRX stock finder (data.krx.co.kr finder_stkisu: full_code = the KRX standard code)",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd  [POST bld=dbms/comm/finder/finder_stkisu, mktsel=ALL]",
    "state": "sourced",
    "value": "KR7293780003"
   },
   "jurisdiction": {
    "read_by": "DART company.json (company profile per corp_code, keyed API) (jurir_no)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://opendart.fss.or.kr/api/company.json?corp_code=01251595",
    "state": "sourced",
    "value": "South Korea (DART filer with a corporate registration number)"
   },
   "lei": {
    "market": "KR",
    "reason": "no GLEIF record registered as 135-86-03821",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "DART company.json (company profile per corp_code, keyed API)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://opendart.fss.or.kr/api/company.json?corp_code=01251595",
    "state": "sourced",
    "value": "Aptabio Therapeutics Inc."
   },
   "sector": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download) (업종)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "자연과학 및 공학 연구개발업"
   },
   "security_type": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "KR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "293780"
   },
   "website": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "http://www.aptabio.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "KR",
  "node": "kr-cm-kg",
  "numbers_hash": "sha256:a4b7bd5d354443024dd2638551f3037e2a38d9aa285224f570c9f7c291f30c02",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2025-12-22",
     "kind": "independent",
     "publisher": "IV Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://aptabio.com/upload/board/information/20251222_073933_138.pdf",
     "state": "sourced",
     "title": "Company Note"
    },
    {
     "date": "2025-02-24",
     "kind": "independent",
     "publisher": "상상인증권리서치센터",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://aptabio.com/upload/board/information/20250224_100737_363.pdf",
     "state": "sourced",
     "title": "압타바이오: 플랫폼 기술기반 First-in-Class 신약개발 전문 기업"
    },
    {
     "date": "2025-01-08",
     "kind": "independent",
     "publisher": "IV Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://aptabio.com/upload/board/information/20250224_105656_425.pdf",
     "state": "sourced",
     "title": "Company Note"
    },
    {
     "date": "2021-12-20",
     "kind": "independent",
     "publisher": "상상인증권리서치센터",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://aptabio.com/upload/board/information/20250224_102110_567.pdf",
     "state": "sourced",
     "title": "2022년 상반기가 중요하다"
    },
    {
     "date": "2020-10-12",
     "kind": "independent",
     "publisher": "Bookook Research Center",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://aptabio.com/upload/board/information/20250224_101525_627.pdf",
     "state": "sourced",
     "title": "Company Report"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.kr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.kr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1",
   "section": "kr.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.kr-cm-kg.ai/record/KOSDAQ/293780",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a4b7bd5d354443024dd2638551f3037e2a38d9aa285224f570c9f7c291f30c02",
 "path": "/kr/KOSDAQ/293780",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Aptabio Therapeutics Inc., listed on KOSDAQ under ticker 293780, with ISIN KR7293780003. The LEI is not on the record; no GLEIF record is registered as 135-86-03821. The security type is Corporate, the segment is not on the record, the sector is 자연과학 및 공학 연구개발업, and the jurisdiction is South Korea as a DART filer with a corporate registration number. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 29 filings across 24 filing days in the window 2025-11-06 to 2026-11-06. The filings are 4 agm_egm, 19 corporate_news, 1 regulatory_filing and 5 results. The median gap between filing days is 8 days. The record date is 2026-11-06, and the latest filing is dated 2026-10-14, a corporate_news filing, 23 days before the record date. The KOSDAQ median is 33 filings, a median cadence gap of 8.0 days and a median latency of 16.0 days across 1819 issuers. The sector median is 42.5 filings, a median cadence gap of 7 days and a median latency of 15 days across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 정진세림회계법인. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The listing, delisting, name change, domicile change and segment move lines are not on the record, because no lifecycle type map exists for this register yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read; the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 5 openly published research notes: IV Research on 2025-12-22, 상상인증권리서치센터 on 2025-02-24, IV Research on 2025-01-08, 상상인증권리서치센터 on 2021-12-20, and Bookook Research Center on 2020-10-12.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "13 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13"
  },
  {
   "for": "identity.isin",
   "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://opendart.fss.or.kr/api/company.json?corp_code=01251595"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSDAQ/293780"
  },
  {
   "for": "the halt flag",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain"
  },
  {
   "for": "the auditor",
   "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323001542"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.kr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://aptabio.com/upload/board/information/20251222_073933_138.pdf"
  },
  {
   "for": "open research",
   "source": "https://aptabio.com/upload/board/information/20250224_100737_363.pdf"
  },
  {
   "for": "open research",
   "source": "https://aptabio.com/upload/board/information/20250224_105656_425.pdf"
  },
  {
   "for": "open research",
   "source": "https://aptabio.com/upload/board/information/20250224_102110_567.pdf"
  },
  {
   "for": "open research",
   "source": "https://aptabio.com/upload/board/information/20250224_101525_627.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.kr-cm-kg.ai/record/KOSDAQ/293780"
  }
 ],
 "title": "Aptabio Therapeutics Inc. (293780) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}